Gremmel, Thomas <br/><br/>
Obesity is associated with poor response to clopidogrel and an increased susceptibility to protease activated receptor-1 mediated platelet activation.  [electronic resource] 

 -  Translational research : the journal of laboratory and clinical medicine  May 2013 
 - 421-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1878-1810 
<br/><br/><label>Standard No.: </label>10.1016/j.trsl.2012.12.015  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Diphosphate--pharmacology<br/>Aged<br/>Angioplasty--adverse effects<br/>Blood Platelets--metabolism<br/>Case-Control Studies<br/>Cell Adhesion Molecules--blood<br/>Clopidogrel<br/>Female<br/>Humans<br/>Male<br/>Microfilament Proteins--blood<br/>Middle Aged<br/>Obesity--blood<br/>P-Selectin--blood<br/>Phosphoproteins--blood<br/>Platelet Activation--drug effects<br/>Platelet Aggregation Inhibitors--pharmacology<br/>Platelet Glycoprotein GPIIb-IIIa Complex--metabolism<br/>Receptor, PAR-1--blood<br/>Stents--adverse effects<br/>Thrombosis--blood<br/>Ticlopidine--analogs & derivatives<br/>Translational Research, Biomedical<br/>Vasodilator-Stimulated Phosphoprotein